• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响风湿科医生在类风湿关节炎中升级治疗决策的因素:基于选择的联合分析结果。

Factors that influence rheumatologists' decisions to escalate care in rheumatoid arthritis: results from a choice-based conjoint analysis.

机构信息

Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.

出版信息

Arthritis Care Res (Hoboken). 2010 Jun;62(6):842-7. doi: 10.1002/acr.20123.

DOI:10.1002/acr.20123
PMID:20535795
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3682224/
Abstract

OBJECTIVE

In order to improve adherence to treatment guidelines and performance indicators advocating tight control of disease activity in rheumatoid arthritis (RA), it is important to gain insight into the factors influencing rheumatologists' decisions whether or not to escalate care. Our objective was to determine the influence of specific attributes relative to a validated measure of disease activity (the Disease Activity Score [DAS]) on rheumatologists' decisions to escalate care.

METHODS

We used a computer-based choice-based conjoint analysis survey to determine the relative importance of 6 attributes on rheumatologists' decisions related to escalation of care in RA. We administered the survey in a convenience sample of rheumatologists attending the 2008 American College of Rheumatology Annual Scientific Meeting. Utilities were calculated using hierarchical Bayes modeling, and these results were used to calculate the relative importance of each attribute.

RESULTS

Rheumatologists assigned the most importance to the DAS score (relative importance of 30.7%) in their decision to escalate care. The age of the patient (21.5%) and erosions (20.5%) were rated as equally important in this decision. The decision to escalate care was least influenced by change in symptoms reported by the patient (11.1%), current treatment (8.9%), and disease duration (7.4%).

CONCLUSION

Our findings suggest that rheumatologists endorse the DAS as a means to guide decision making in RA. We also found that age and erosions are important influences on rheumatologists' decisions to escalate care in RA. Our results add to the literature supporting age bias in RA and suggest that further research is needed to determine how age affects quality of care in clinical practice.

摘要

目的

为了提高对治疗指南的依从性,并实现类风湿关节炎(RA)疾病活动度严格控制的绩效指标,深入了解影响风湿病学家决定是否升级治疗的因素非常重要。我们的目的是确定相对于疾病活动度的验证衡量标准(疾病活动评分[DAS])的特定属性对风湿病学家决定升级护理的影响。

方法

我们使用基于计算机的选择式联合分析调查来确定与 RA 中护理升级相关的风湿病学家决策中 6 个属性的相对重要性。我们在参加 2008 年美国风湿病学会年会的便利样本风湿病学家中进行了这项调查。使用分层贝叶斯模型计算效用,并使用这些结果计算每个属性的相对重要性。

结果

风湿病学家将 DAS 评分(相对重要性为 30.7%)在其决定升级护理中的重要性评定为最高。患者的年龄(21.5%)和侵蚀(20.5%)在该决策中被评定为同等重要。患者报告的症状变化(11.1%)、当前治疗(8.9%)和疾病持续时间(7.4%)对升级护理的决策影响最小。

结论

我们的研究结果表明,风湿病学家认可 DAS 是指导 RA 决策的一种手段。我们还发现年龄和侵蚀是影响风湿病学家决定升级 RA 护理的重要因素。我们的研究结果为 RA 中的年龄偏见提供了更多的文献支持,并表明需要进一步研究确定年龄如何影响临床实践中的护理质量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccce/3682224/872b3edecf8d/nihms469266f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccce/3682224/1546a53a290f/nihms469266f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccce/3682224/a1535c8c0ced/nihms469266f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccce/3682224/872b3edecf8d/nihms469266f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccce/3682224/1546a53a290f/nihms469266f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccce/3682224/a1535c8c0ced/nihms469266f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccce/3682224/872b3edecf8d/nihms469266f3.jpg

相似文献

1
Factors that influence rheumatologists' decisions to escalate care in rheumatoid arthritis: results from a choice-based conjoint analysis.影响风湿科医生在类风湿关节炎中升级治疗决策的因素:基于选择的联合分析结果。
Arthritis Care Res (Hoboken). 2010 Jun;62(6):842-7. doi: 10.1002/acr.20123.
2
Rheumatoid arthritis patients and rheumatologists approach the decision to escalate care differently: results of a maximum difference scaling experiment.类风湿关节炎患者和风湿病专家在决定升级治疗方案时的看法存在差异:最大差异标度实验的结果。
Arthritis Care Res (Hoboken). 2011 Oct;63(10):1407-14. doi: 10.1002/acr.20551.
3
Determining rheumatologists' accuracy at assessing functional disability in rheumatoid arthritis patients using the Health Assessment Questionnaire-Disability Index.使用健康评估问卷-残疾指数来确定风湿病学家评估类风湿关节炎患者功能残疾的准确性。
J Rheumatol. 2007 May;34(5):958-63. Epub 2007 Apr 1.
4
What Matters Most to Patients and Rheumatologists? A Discrete Choice Experiment in Rheumatoid Arthritis.患者和风湿病专家最看重什么?类风湿关节炎中的离散选择实验。
Adv Ther. 2020 Apr;37(4):1479-1495. doi: 10.1007/s12325-020-01258-5. Epub 2020 Feb 22.
5
Rheumatologists' adherence to a disease activity score steered treatment protocol in early arthritis patients is less if the target is remission.对于早期关节炎患者,如果目标是实现病情缓解,风湿病学家对基于疾病活动评分的治疗方案的依从性会降低。
Clin Rheumatol. 2017 Feb;36(2):317-326. doi: 10.1007/s10067-016-3405-8. Epub 2016 Sep 28.
6
Factors that impact decision making among rheumatologists in the initiation of treatment for hypertension in rheumatoid arthritis.影响风湿病学家对类风湿关节炎患者启动高血压治疗决策的因素。
J Clin Rheumatol. 2007 Dec;13(6):307-12. doi: 10.1097/RHU.0b013e318156bcc2.
7
Rheumatologists' guideline adherence in rheumatoid arthritis: a randomised controlled study on electronic decision support, education and feedback.类风湿关节炎中风湿病学家对指南的遵循情况:一项关于电子决策支持、教育与反馈的随机对照研究
Clin Exp Rheumatol. 2018 Jan-Feb;36(1):21-28. Epub 2017 Jun 5.
8
Factors influencing rheumatologists' prescription of biological treatment in rheumatoid arthritis: an interview study.影响类风湿关节炎中风湿病学家生物治疗处方的因素:一项访谈研究。
Implement Sci. 2014 Oct 11;9:153. doi: 10.1186/s13012-014-0153-5.
9
Doctors' preferences in de-escalating DMARDs in rheumatoid arthritis: a discrete choice experiment.类风湿关节炎中医生在逐步减少改善病情抗风湿药(DMARDs)治疗方面的偏好:一项离散选择实验
Arthritis Res Ther. 2017 Apr 26;19(1):78. doi: 10.1186/s13075-017-1287-z.
10
Are rheumatologists' treatment decisions influenced by patients' age?风湿病专家的治疗决策会受到患者年龄的影响吗?
Rheumatology (Oxford). 2006 Dec;45(12):1555-7. doi: 10.1093/rheumatology/kel144. Epub 2006 May 11.

引用本文的文献

1
The effect of polypharmacy on rheumatoid and psoriatic arthritis treatment: retrospective study.多药治疗对类风湿性关节炎和银屑病关节炎治疗的影响:回顾性研究。
PeerJ. 2023 Nov 22;11:e16418. doi: 10.7717/peerj.16418. eCollection 2023.
2
Towards Personalising the Use of Biologics in Rheumatoid Arthritis: A Discrete Choice Experiment.迈向类风湿关节炎生物制剂个体化应用:离散选择实验。
Patient. 2022 Jan;15(1):109-119. doi: 10.1007/s40271-021-00533-z. Epub 2021 Jun 18.
3
Determinants of the Physician Global Assessment of Disease Activity and Influence of Contextual Factors in Early Axial Spondyloarthritis.

本文引用的文献

1
Missed opportunities in the treatment of elderly patients with rheumatoid arthritis.老年类风湿关节炎患者治疗中的错失良机
Rheumatology (Oxford). 2009 Aug;48(8):906-10. doi: 10.1093/rheumatology/kep129. Epub 2009 May 28.
2
The uses of disease activity scoring and the physician global assessment of disease activity for managing rheumatoid arthritis in rheumatology practice.疾病活动评分和医生对疾病活动的整体评估在风湿病学实践中用于管理类风湿关节炎的用途。
J Rheumatol. 2009 May;36(5):925-9. doi: 10.3899/jrheum.081046. Epub 2009 Apr 15.
3
Changing patterns of tumor necrosis factor inhibitor use in 9074 patients with rheumatoid arthritis.
早期中轴型脊柱关节炎的疾病活动度的医师整体评估及背景因素影响的决定因素。
Arthritis Care Res (Hoboken). 2022 Feb;74(2):268-273. doi: 10.1002/acr.24465. Epub 2022 Jan 13.
4
Examining Treatment Decision-Making Among Patients With Axial Spondyloarthritis: Insights From a Conjoint Analysis Survey.研究中轴型脊柱关节炎患者的治疗决策:联合分析调查的见解
ACR Open Rheumatol. 2020 Jul;2(7):391-400. doi: 10.1002/acr2.11151. Epub 2020 Jun 9.
5
Efficacy and Safety of Etanercept in Elderly Patients with Rheumatoid Arthritis: A Post-Hoc Analysis of Randomized Controlled Trials.依那西普治疗老年类风湿关节炎患者的疗效和安全性:随机对照试验的事后分析。
Drugs Aging. 2019 Sep;36(9):853-862. doi: 10.1007/s40266-019-00691-8.
6
Biologic treatment of Japanese patients with inflammatory bowel disease.日本炎症性肠病患者的生物治疗。
BMC Gastroenterol. 2018 Nov 1;18(1):160. doi: 10.1186/s12876-018-0892-x.
7
Using subcutaneous methotrexate to prolong duration of methotrexate therapy in rheumatoid arthritis.使用皮下注射甲氨蝶呤延长类风湿关节炎中甲氨蝶呤治疗的疗程。
Eur J Rheumatol. 2018 Jul;5(2):85-91. doi: 10.5152/eurjrheum.2018.17113. Epub 2018 Feb 13.
8
Pharmacotherapy Pearls in Rheumatology for the Care of Older Adult Patients: Focus on Oral Disease-Modifying Antirheumatic Drugs and the Newest Small Molecule Inhibitors.老年患者风湿病治疗的药物治疗要点:聚焦口服改善病情抗风湿药及最新小分子抑制剂
Rheum Dis Clin North Am. 2018 Aug;44(3):371-391. doi: 10.1016/j.rdc.2018.03.010. Epub 2018 Jun 12.
9
What Drives Patient Choice: Preferences for Approaches to Surgical Treatments for Breast Cancer Beyond Traditional Clinical Benchmarks.是什么驱动患者的选择:超越传统临床标准的乳腺癌外科治疗方法偏好
Plast Reconstr Surg Glob Open. 2018 Apr 20;6(4):e1746. doi: 10.1097/GOX.0000000000001746. eCollection 2018 Apr.
10
Optimizing Selection of Biologics in Inflammatory Bowel Disease: Development of an Online Patient Decision Aid Using Conjoint Analysis.优化炎症性肠病生物制剂的选择:使用联合分析开发在线患者决策辅助工具。
Am J Gastroenterol. 2018 Jan;113(1):58-71. doi: 10.1038/ajg.2017.470. Epub 2017 Dec 5.
9074例类风湿关节炎患者使用肿瘤坏死因子抑制剂的模式变化
J Rheumatol. 2009 May;36(5):907-13. doi: 10.3899/jrheum.080592. Epub 2009 Mar 30.
4
Proposed metrics for the determination of rheumatoid arthritis outcome and treatment success and failure.用于确定类风湿性关节炎结局以及治疗成败的拟议指标。
J Rheumatol. 2009 Jan;36(1):27-33. doi: 10.3899/jrheum.080591.
5
Influence of age on the outcome of antitumour necrosis factor alpha therapy in rheumatoid arthritis.年龄对类风湿关节炎中抗肿瘤坏死因子α治疗结果的影响。
Ann Rheum Dis. 2009 Sep;68(9):1470-3. doi: 10.1136/ard.2008.094730. Epub 2008 Nov 17.
6
Development and validation of a patient-based disease activity score in rheumatoid arthritis that can be used in clinical trials and routine practice.类风湿关节炎中一种基于患者的疾病活动评分的开发与验证,该评分可用于临床试验和日常实践。
Arthritis Rheum. 2008 Feb 15;59(2):192-9. doi: 10.1002/art.23342.
7
Treatment of older adult patients diagnosed with rheumatoid arthritis: improved but not optimal.对被诊断为类风湿性关节炎的老年患者的治疗:有所改善但未达最佳状态。
Arthritis Rheum. 2007 Aug 15;57(6):928-34. doi: 10.1002/art.22890.
8
Resistance of rheumatoid arthritis patients to changing therapy: discordance between disease activity and patients' treatment choices.类风湿关节炎患者对改变治疗方案的抵抗:疾病活动度与患者治疗选择之间的不一致。
Arthritis Rheum. 2007 Jul;56(7):2135-42. doi: 10.1002/art.22719.
9
Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial).甲氨蝶呤强化治疗早期类风湿关节炎:旨在实现缓解。早期类风湿关节炎的计算机辅助管理(CAMERA,一项开放标签策略试验)。
Ann Rheum Dis. 2007 Nov;66(11):1443-9. doi: 10.1136/ard.2007.071092. Epub 2007 May 22.
10
Tolerance and effectiveness of anti-tumor necrosis factor alpha therapies in elderly patients with rheumatoid arthritis: a population-based cohort study.老年类风湿关节炎患者中抗肿瘤坏死因子α治疗的耐受性和有效性:一项基于人群的队列研究。
Arthritis Rheum. 2007 May 15;57(4):679-85. doi: 10.1002/art.22688.